Skip to main content
Helena Rodbard, MD, Endocrinology, Rockville, MD

HelenaWRodbardMDMACE FACP

Endocrinology Rockville, MD

Diabetes, Lipid Metabolism

Endocrine and Metabolic Associates

Dr. Rodbard is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Rodbard's full profile

Already have an account?

  • Office

    3200 Tower Oaks Blvd
    Ste 250
    Rockville, MD 20852
    Phone+1 301-770-7373
    Fax+1 301-770-7272

Education & Training

  • George Washington University
    George Washington UniversityFellowship, Endocrinology, Diabetes, and Metabolism, 1981 - 1982
  • MedStar Health/Georgetown-Washington Hospital Center
    MedStar Health/Georgetown-Washington Hospital CenterResidency, Internal Medicine, 1979 - 1981
  • Paulista School of Medicine
    Paulista School of MedicineClass of 1972

Certifications & Licensure

  • MD State Medical License
    MD State Medical License 1979 - 2025
  • DC State Medical License
    DC State Medical License 1982 - 2000
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Endocrinology, Diabetes and Metabolism

Awards, Honors, & Recognition

  • America's Top Doctors Castle Connolly, 2011-2014
  • Top Doctors:Washington DC Area Castle Connolly, 2012
  • Top Doctors:Baltimore Area Castle Connolly, 2012
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • Effect of Sotagliflozin as an Adjunct to Insulin Therapy on Blood Pressure and Arterial Stiffness in Adults with Type 1 Diabetes: A Post Hoc Pooled Analysis of inTandem1 and inTandem2
    Effect of Sotagliflozin as an Adjunct to Insulin Therapy on Blood Pressure and Arterial Stiffness in Adults with Type 1 Diabetes: A Post Hoc Pooled Analysis of inTandem1 and inTandem2February 20th, 2021
  • Treating Hypertension Reduces CV Risks in Diabetes Care
    Treating Hypertension Reduces CV Risks in Diabetes CareAugust 8th, 2019
  • Europe Embraces, FDA Rejects Use of SGLT Inhibitors for Type 1 Diabetes
    Europe Embraces, FDA Rejects Use of SGLT Inhibitors for Type 1 DiabetesJuly 23rd, 2019
  • Join now to see all

Committees

  • member, AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS MEDICAL GUIDELINES FOR CLINICAL PRACTICE FOR THE MANAGEMENT OF DIABETES MELLITUS

Professional Memberships

Other Languages

  • Spanish, Portuguese